Cargando…

Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study

AIMS: Prior studies have suggested that the benefit from primary preventive defibrillator treatment for patients with nonischemic cardiomyopathyy, treated with cardiac resynchronization therapy, may be age-dependent. We aimed to compare age-stratified mortality rates and mode of death in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farouq, Maiwand, Rorsman, Cecilia, Marinko, Sofia, Mörtsell, David, Chaudhry, Uzma, Wang, Lingwei, Platonov, Pyotr G, Borgquist, Rasmus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368447/ https://www.ncbi.nlm.nih.gov/pubmed/37392462 http://dx.doi.org/10.1093/europace/euad187

Ejemplares similares

Maximizing QRS duration reduction in contemporary cardiac resynchronization therapy is feasible and shorter QRS duration is associated with better clinical outcome
por: Borgquist, Rasmus, et al.
Publicado: (2023)

Repositioning and optimization of left ventricular lead position in nonresponders to cardiac resynchronization therapy is associated with improved ejection fraction, lower NT-proBNP values, and fewer heart failure symptoms
por: Borgquist, Rasmus, et al.
Publicado: (2022)

Association between left ventricular lead position and intrinsic QRS morphology with regard to clinical outcome in cardiac resynchronization therapy for heart failure
por: Brandtvig, Tove Olsson, et al.
Publicado: (2023)

Successful percutaneous extraction of malpositioned pacemaker lead in the left ventricle after proper dabigatran treatment
por: Farouq, Maiwand, et al.
Publicado: (2022)

Baseline QRS Area and Reduction in QRS Area Are Associated with Lower Mortality and Risk of Heart Failure Hospitalization after Cardiac Resynchronization Therapy
por: Marinko, Sofia, et al.
Publicado: (2022)

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
por: Liu, Fuwei, et al.
Publicado: (2023)

Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy
por: Jacobsson, Jonatan, et al.
Publicado: (2019)

Anatomy of the coronary sinus with regard to cardiac resynchronization therapy implantation
por: Borgquist, Rasmus, et al.
Publicado: (2022)

Implantable cardioverter defibrillator in nonischemic cardiomyopathy: A systematic review and meta‐analysis
por: Khan, Safi U., et al.
Publicado: (2017)

Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

The mortality for the implantable cardiac defibrillator in nonischemic cardiomyopathy: An updated systematic review and meta‐analysis
por: He, Wenfeng, et al.
Publicado: (2022)

Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator
por: Zhou, Bin, et al.
Publicado: (2020)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Biventricular thrombi of nonischemic cardiomyopathy
por: Adnan, Mohammed Muqeet, et al.
Publicado: (2014)

Ventricular arrhythmias in nonischemic cardiomyopathy
por: Chung, Fa‐Po, et al.
Publicado: (2018)

Sibutramine-Induced Nonischemic Cardiomyopathy
por: Shah, Meet S, et al.
Publicado: (2022)

The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure
por: Nomoto, Michiru, et al.
Publicado: (2022)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
por: Kusano, Kengo
Publicado: (2018)

Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
por: Okubo, Kenji, et al.
Publicado: (2018)

Bevacizumab: A Rare Cause of Nonischemic Cardiomyopathy
por: Oladiran, Oreoluwa, et al.
Publicado: (2018)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Cardiomyocyte Regeneration in the mdx Mouse Model of Nonischemic Cardiomyopathy
por: Richardson, Gavin David, et al.
Publicado: (2015)

Added value of contrast echocardiography in characterization of nonischemic cardiomyopathy
por: Pi, Shufang, et al.
Publicado: (2018)

A Rare Case of Phentermine-Induced Nonischemic Cardiomyopathy
por: Damani, Devanshi, et al.
Publicado: (2022)

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
por: Leyva, Francisco, et al.
Publicado: (2018)

Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
por: Samy, Mohammed, et al.
Publicado: (2023)

Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members
por: Saberniak, Jørg, et al.
Publicado: (2014)

Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients
por: Xu, Yifei, et al.
Publicado: (2013)

Predictors of Right Ventricular Ejection Fraction in Patients with Nonischemic Cardiomyopathy
por: Sabe, Sharif A, et al.
Publicado: (2016)

Left Ventricular Noncompaction: A Rare Case of Nonischemic Cardiomyopathy
por: Tian, Julia, et al.
Publicado: (2019)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
por: Lawson, Mark A., et al.
Publicado: (2021)

Trypanosoma cruzi in Nonischemic Cardiomyopathy Patients, Houston, Texas, USA
por: Nolan, Melissa S., et al.
Publicado: (2021)

Serum albumin and prognosis in elderly patients with nonischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2023)

Epsilon Waves as an Extreme Form of Depolarization Delay: Focusing on the Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Platonov, Pyotr G., et al.
Publicado: (2021)

Mortality among ischemic and nonischemic heart failure patients with a primary implantable cardioverter‐defibrillator
por: Yang, Pil‐Sung, et al.
Publicado: (2021)

Ivabradine Improves Heart Rate Variability in Patients with Nonischemic Dilated Cardiomyopathy
por: Kurtoglu, Ertugrul, et al.
Publicado: (2014)

Mitochondrial Ca(2+) Influx Contributes to Arrhythmic Risk in Nonischemic Cardiomyopathy
por: Xie, An, et al.
Publicado: (2018)

Successful Substrate Ablation for Ventricular Fibrillation in a Patient With Nonischemic Cardiomyopathy
por: Yamaguchi, Junji, et al.
Publicado: (2021)

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
por: Luo, Nancy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2nepc8erj92najb3io1qpfj37t